Table 3. OSCC compared with oral cavity controls.
| Probeset name | P-value | q-value (FDR) | Fold change SCC/control |
|---|---|---|---|
| hsa-miR-375_st | 1.35E-16 | 3.49E-14 | −20 |
| hsa-miR-1224-5p_st | 4.48E-18 | 3.47E-15 | −11.1 |
| hsa-miR-617_st | 8.22E-17 | 3.19E-14 | −8.3 |
| hsa-miR-99a_st | 1.13E-12 | 2.18E-10 | −5.3 |
| hsa-miR-125b_st | 4.8E-07 | 0.0000233 | −2.3 |
| hsa-miR-378_st | 2.09E-06 | 0.0000676 | −2.1 |
| hsa-miR-27b_st | 1.14E-06 | 0.0000422 | −2 |
| hsa-miR-125b-2-star_st | 4.14E-06 | 0.000107 | −2 |
| hsa-miR-21-star_st | 3.14E-07 | 0.0000162 | 2 |
| hsa-miR-345_st | 6.68E-06 | 0.000157 | 2.1 |
| hsa-miR-106b-star_st | 2.58E-06 | 0.0000768 | 2.2 |
| hsa-miR-132_st | 6.91E-07 | 0.0000297 | 2.3 |
| hsa-miR-27a-star_st | 5.35E-10 | 5.93E-08 | 2.4 |
| hsa-miR-181b_st | 8.05E-08 | 0.00000567 | 2.4 |
| hsa-miR-181a_st | 1.54E-07 | 0.00000918 | 2.4 |
| hsa-miR-424-star_st | 7.77E-10 | 7.53E-08 | 2.9 |
| hsa-miR-155_st | 8.41E-07 | 0.0000326 | 2.9 |
| hsa-miR-146a_st | 7.57E-07 | 0.0000309 | 3 |
| hsa-miR-146b-5p_st | 1.26E-07 | 0.00000816 | 3.1 |
| hsa-miR-1246_st | 4.53E-08 | 0.00000351 | 3.6 |
| hsa-miR-187_st | 2.02E-09 | 0.000000174 | 3.8 |
| hsa-miR-503_st | 1.81E-12 | 2.81E-10 | 4.2 |
| hsa-miR-223_st | 2.25E-06 | 0.0000698 | 4.26 |
| hsa-miR-21_st | 9.2E-11 | 1.19E-08 | 5.6 |
| hsa-miR-31_st | 1.79E-06 | 0.000063 | 6.85 |
Abbreviations: FDR=false discovery rate; miRNA=microRNA; OSCC=oral squamous cell carcinoma.
Top 25 significant differentially expressed miRNAs with fold change of more than 2.